Solid Biosciences Inc (SLDB) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Solid Biosciences Inc   (NASDAQ: SLDB)


Solid Biosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Solid Biosciences Inc's ROI in the second quarter of 2026?
Solid Biosciences Inc recorded a cumulative net loss of $-207 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -67.47%.

Within the Healthcare sector 462 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3573 to 3825.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 29.68 % 26.7 % 30.38 % 26.29 % 22.97 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 392 395 201 240 281
Return On Investment (TTM) -67.47 % -68.66 % -67.02 % -67.01 % -65.1 %
SLDB's Overall Ranking # 3825 # 3573 # 3503 # 3600 # 3158
Seq. Investment Change TTM 9.9 % 7.37 % 4.29 % 5.38 % 7.38 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -207 -192 -174 -167 -154

SLDB Company Profile >> Back to SLDB Roi Comparisons >> See Annual SLDB Return On Investment



Return On Investment SLDB's Ranking
Within: No.
Industry # 76
Sector # 463
Overall # 3825

Return On Investment Statistics
High Average Low
-30.69 %
-67.56 %
-182.25 %
(Dec 31 2021)   (Sep 30 2020)



  News about Solid Biosciences Inc Return on Investment ROI

Solid Biosciences Employs Incentives to Attract Top Talent While Navigating Market Fluctuations in Pursuit of Genetic Therapies

April 3, 2024

Solid Biosciences Grants Inducement Awards to Newly Hired Employees, Share Price Dips in Q2 2024
CHARLESTOWN, Mass., April 03, 2024 - Solid Biosciences Inc. (Nasdaq: SLDB), a leading life sciences company focusing on precision genetic medicines for neuromuscular and cardiac diseases, has recently announced the granting of inducement awards to two individuals who have joined the organization. These grants were awarded as part of the company s 2024 Inducement Stock Incentive Plan and were intended to serve as motivation for the employees to accept their positions at Solid Biosciences, in compliance with Nasdaq Listing Rule 5635(c)(4).
Solid Biosciences, recognized for its pioneering work and commitment to developing transformative genetic therapies, sees these inducement awards as an essential tool for attracting and retaining top talent in a highly competitive industry. The company firmly believes that the skills and expertise of these two individuals will greatly contribute to its groundbreaking research and development efforts in the coming years.





Financial Statements
Solid Biosciences Inc's II. Quarter Investments $ 392 Millions SLDB's Balance sheet
Solid Biosciences Inc's II. Quarter Income $ -55 Millions Quarterly SLDB's Income Statement
SLDB's Income by Division See SLDB's Income by Division


SLDB Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 180 158 150 238 209
Y / Y Investment Growth 13.64 % 5.31 % -36.73 % 13.87 % 42.33 %
Net Income in Millions -174 -125 -96 -86 -72
Y / Y Net Income Growth - - - - -
Annual Return On Investment -96.84 % -78.72 % -63.83 % -36.17 % -34.58 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SLDB's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SLDB's Competitors
Subscribers only: Roi for Solid Biosciences Inc's Suppliers
Subscribers only: Return On Investment for SLDB's Customers

Other Ratios
SLDB's Roa SLDB's Inventory Turnover Ratio SLDB's Growth Rates SLDB's Dividend Statistics
SLDB's Profitability Ratios SLDB's Asset Turnover Ratio SLDB's Dividend Growth
SLDB's Roe SLDB's Valuation Ratios SLDB's Financial Strength Ratios SLDB's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:33:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.